Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J McConkey

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
Current Oncology Reports|August 22, 2018
Molecular Subtypes of Bladder CancerDavid J McConkey, Woonyoung Choi
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2004
Measurement of changes in intracellular calcium during apoptosisDavid J McConkey, Leta Nutt
Journal of the National Cancer Institute|January 18, 2018
Subtyping Bladder Cancers: Biology vs BioinformaticsDavid J McConkey, Woonyoung Choi
Cancer Metastasis Reviews|December 17, 2009
Urological cancers. PrefaceDavid J McConkey, Colin Dinney
World Journal of Urology|December 15, 2018
SIU-ICUD consultation on bladder cancer: basic scienceDavid J McConkey, Seth P Lerner
Cancer Prevention Research (Philadelphia, Pa.)|December 3, 2009
The molecular, the bad, and the ugly: preventing bladder cancer via mTOR inhibitionDavid J McConkey, Colin P Dinney
European Urology|June 4, 2019
Limited Upstaging in Luminal Subtype Tumors: Ready for Clinical Practice?Joshua J Meeks, David J McConkey
Cancer Research|November 13, 2003
The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cellsSimon A Williams, David J McConkey
The Prostate|March 29, 2002
Anoikis is regulated by BCL-2-independent pathways in human prostate carcinoma cellsVictor M Bondar, David J McConkey
European Urology|August 24, 2015
Bridging the Gap in Upper Tract Urothelial CarcinomaSurena F Matin, David J McConkey
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
Current Oncology Reports|August 22, 2018
Molecular Subtypes of Bladder CancerDavid J McConkey, Woonyoung Choi
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2004
Measurement of changes in intracellular calcium during apoptosisDavid J McConkey, Leta Nutt
Journal of the National Cancer Institute|January 18, 2018
Subtyping Bladder Cancers: Biology vs BioinformaticsDavid J McConkey, Woonyoung Choi
Cancer Metastasis Reviews|December 17, 2009
Urological cancers. PrefaceDavid J McConkey, Colin Dinney
World Journal of Urology|December 15, 2018
SIU-ICUD consultation on bladder cancer: basic scienceDavid J McConkey, Seth P Lerner
Cancer Prevention Research (Philadelphia, Pa.)|December 3, 2009
The molecular, the bad, and the ugly: preventing bladder cancer via mTOR inhibitionDavid J McConkey, Colin P Dinney
European Urology|June 4, 2019
Limited Upstaging in Luminal Subtype Tumors: Ready for Clinical Practice?Joshua J Meeks, David J McConkey
Cancer Research|November 13, 2003
The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cellsSimon A Williams, David J McConkey
The Prostate|March 29, 2002
Anoikis is regulated by BCL-2-independent pathways in human prostate carcinoma cellsVictor M Bondar, David J McConkey
European Urology|August 24, 2015
Bridging the Gap in Upper Tract Urothelial CarcinomaSurena F Matin, David J McConkey
Pageof 21